Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$24,900.00
Jun 1, 2025
For-profit organization
Commercialization Strategy for Marketing Finished Product
1031097
The project will prepare a portfolio for commercialization of the product to launch to market.
$48,000.00
Apr 1, 2023
For-profit organization
Refinement of Foam for Treatment of Inflammatory Disease
1004332
This project will develop of a new nanotechnology anti-inflammatory foam formulation.
$50,000.00
Jan 17, 2022
For-profit organization
Development of Nanotechnology Based Foam for the Topical Treatment of Inflammatory Disease
984528
The project will develop a medicated topical foam for the treatment of inflammatory diseases like rheumatoid arthritis, osteoarthritis, joint and/or back pain due to injuries. A localized treatment of inflammation will lower the systemic exposure of the drug and this will decrease possible side effects.